Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07837284Phase 1Not yet recruiting
Phase 1, randomised, open-label trial of diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Florida State University. Primary endpoints: Feasibility of Recruitment and Enrollment at 6 months, Theoretical Framework of Acceptability Questionnaire at 33 days and 2 more. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07837284.